CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02905578
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-24T00:07:48.463221+00:00
Published At: 2026-07-23T00:00:00+00:00
Record Updated At: 2026-07-23
Results Posted At: 2026-07-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pancreatic Neoplasms", "Cancer of Pancreas", "Cancer of the Pancreas", "Neoplasms, Pancreatic", "Pancreas Cancer", "Pancreas Neoplasms", "Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-23"
protocolSection.identificationModule.nctId: "NCT02905578"
protocolSection.identificationModule.officialTitle: "A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-07-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.